Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light

Choi, JiwoongLee, Il SeongLee, Ju SeungJeon, SangminYun, Wan SuYang, SuahMoon, YujeongKim, JinseongKim, JeongraeChoy, SeunghwanJeong, ChanhoShim, Man KyuKim, Tae-Il김광명
Issue Date
The Korean Society for Biomaterials | BioMed Central
Biomaterials Research, v.26, no.1, pp.1019 - 1033
Background Photodynamic therapy (PDT) is a promising strategy to promote antitumor immunity by inducing immunogenic cell death (ICD) in tumor cells. However, practical PDT uses an intense visible light owing to the shallow penetration depth of the light, resulting in immunosuppression at the tumor tissues. Methods Herein, we propose an implantable micro-scale light-emitting diode device (micro-LED) guided PDT that enables the on-demand light activation of photosensitizers deep in the body to potentiate antitumor immunity with mild visible light. Results The micro-LED is prepared by stacking one to four micro-scale LEDs (100 mu m) on a needle-shape photonic device, which can be directly implanted into the core part of the tumor tissue. The photonic device with four LEDs efficiently elicits sufficient light output powers without thermal degradation and promotes reactive oxygen species (ROS) from a photosensitizer (verteporfin; VPF). After the intravenous injection of VPF in colon tumor-bearing mice, the tumor tissues are irradiated with optimal light intensity using an implanted micro-LED. While tumor tissues under intense visible light causes immunosuppression by severe inflammatory responses and regulatory T cell activation, mild visible light elicits potent ICD in tumor cells, which promotes dendritic cell (DC) maturation and T cell activation. The enhanced therapeutic efficacy and antitumor immunity by micro-LED guided PDT with mild visible light are assessed in colon tumor models. Finally, micro-LED guided PDT in combination with immune checkpoint blockade leads to 100% complete tumor regression and also establishes systemic immunological memory to prevent the recurrence of tumors. Conclusion Collectively, this study demonstrates that micro-LED guided PDT with mild visible light is a promising strategy for cancer immunotherapy.
ME; Implantable photonic device; cancer immunotherapy; Photodynamic therapy; Immune checkpoint blockade; Cell death and immune response
Appears in Collections:
KIST Article > 2022
Files in This Item:
There are no files associated with this item.
RIS (EndNote)
XLS (Excel)


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.